ebook: Optimise your high value cell lines
Posted: 30 June 2021 | Molecular Devices | No comments yet
As interest in biotherapeutic proteins grows, the need to reduce cell line development costs and the time to market is more critical than ever.
During the last decade, production of monoclonal antibodies (mAbs) and recombinant proteins using mammalian cells has led to a boom in the introduction of biotherapeutic proteins to the market. In this ebook, we present an overview of the cell line development workflow as well as high throughput solutions for accelerating the process, and enabling easier and faster selection of high-producing mammalian cell lines.
Related content from this organisation
Related topics
Analytical Techniques, Antibodies, Assays, Biopharmaceuticals, Disease Research, Imaging, Immunology, Lab Automation, Microscopy, Proteomics, Stem Cells, Targets
Related organisations
Molecular Devices
